New oral pill H021 aims to tame Crohn's Flare-Ups
Disease control
Not yet recruiting
This phase 2 trial tests whether an experimental oral tablet called H021 can help people with moderate to severe Crohn's disease. Participants receive either a low or high dose of H021 or a placebo for 12 weeks, with an option to continue treatment. The study measures symptom imp…
Phase: PHASE2 • Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC